Report Detail
Global (United States, European Union and China) Diphtheria, Pertussis, and Tetanus Vaccine Market Research Report 2019-2025
- RnM3687926 |
- 21 August, 2019 |
- Global |
- 119 Pages |
- QYResearch |
- Chemical & Material
Diphtheria, pertussis, and tetanus (DPT) vaccine is administered for three infectious diseases in humans-diphtheria, tetanus, and pertussis. They are administered either in childhood or middle age to produce the acquired immunity against diphtheria, pertussis, and tetanus.
In 2019, the market size of Diphtheria, Pertussis, and Tetanus Vaccine is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Diphtheria, Pertussis, and Tetanus Vaccine.
This report studies the global market size of Diphtheria, Pertussis, and Tetanus Vaccine, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Diphtheria, Pertussis, and Tetanus Vaccine production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Johnson & Johnson
GlaxoSmithKline
Sanofi
Lanzhou Institute of Biological
Merck
Novartis
AstraZeneca
Emergent
Astellas
Market Segment by Product Type
DTaP
Td
Tdap
Market Segment by Application
Hospitals
Clinics
Vaccination Centers
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Diphtheria, Pertussis, and Tetanus Vaccine status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Diphtheria, Pertussis, and Tetanus Vaccine manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Diphtheria, Pertussis, and Tetanus Vaccine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Research Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size Growth Rate by Type (2019-2025)
- 1.3.2 DTaP
- 1.3.3 Td
- 1.3.4 Tdap
- 1.4 Market Segment by Application
- 1.4.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Share by Application (2019-2025)
- 1.4.2 Hospitals
- 1.4.3 Clinics
- 1.4.4 Vaccination Centers
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Production and Capacity Analysis
- 2.1.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Value 2014-2025
- 2.1.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Production 2014-2025
- 2.1.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Capacity 2014-2025
- 2.1.4 Global Diphtheria, Pertussis, and Tetanus Vaccine Marketing Pricing and Trends
- 2.2 Key Producers Growth Rate (CAGR) 2019-2025
- 2.2.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size CAGR of Key Regions
- 2.2.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Share of Key Regions
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Capacity and Production by Manufacturers
- 3.1.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Capacity by Manufacturers
- 3.1.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Production by Manufacturers
- 3.2 Revenue by Manufacturers
- 3.2.1 Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Manufacturers (2014-2019)
- 3.2.2 Diphtheria, Pertussis, and Tetanus Vaccine Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Concentration Ratio (CR5 and HHI)
- 3.3 Diphtheria, Pertussis, and Tetanus Vaccine Price by Manufacturers
- 3.4 Key Manufacturers Diphtheria, Pertussis, and Tetanus Vaccine Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Diphtheria, Pertussis, and Tetanus Vaccine Market
- 3.6 Key Manufacturers Diphtheria, Pertussis, and Tetanus Vaccine Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Production and Production Value for Each Type
- 4.1.1 DTaP Production and Production Value (2014-2019)
- 4.1.2 Td Production and Production Value (2014-2019)
- 4.1.3 Tdap Production and Production Value (2014-2019)
- 4.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Market Share by Type
- 4.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Value Market Share by Type
- 4.4 Diphtheria, Pertussis, and Tetanus Vaccine Ex-factory Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Application
6 Production by Regions
- 6.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Production (History Data) by Regions 2014-2019
- 6.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Value (History Data) by Regions
- 6.3 United States
- 6.3.1 United States Diphtheria, Pertussis, and Tetanus Vaccine Production Growth Rate 2014-2019
- 6.3.2 United States Diphtheria, Pertussis, and Tetanus Vaccine Production Value Growth Rate 2014-2019
- 6.3.3 Key Players in United States
- 6.3.4 United States Diphtheria, Pertussis, and Tetanus Vaccine Import & Export
- 6.4 European Union
- 6.4.1 European Union Diphtheria, Pertussis, and Tetanus Vaccine Production Growth Rate 2014-2019
- 6.4.2 European Union Diphtheria, Pertussis, and Tetanus Vaccine Production Value Growth Rate 2014-2019
- 6.4.3 Key Players in European Union
- 6.4.4 European Union Diphtheria, Pertussis, and Tetanus Vaccine Import & Export
- 6.5 China
- 6.5.1 China Diphtheria, Pertussis, and Tetanus Vaccine Production Growth Rate 2014-2019
- 6.5.2 China Diphtheria, Pertussis, and Tetanus Vaccine Production Value Growth Rate 2014-2019
- 6.5.3 Key Players in China
- 6.5.4 China Diphtheria, Pertussis, and Tetanus Vaccine Import & Export
- 6.6 Rest of World
- 6.6.1 Japan
- 6.6.2 Korea
- 6.6.3 India
- 6.6.4 Southeast Asia
7 Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Regions
- 7.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Consumption (History Data) by Regions
- 7.2 United States
- 7.2.1 United States Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Type
- 7.2.2 United States Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Application
- 7.3 European Union
- 7.3.1 European Union Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Type
- 7.3.2 European Union Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Application
- 7.4 China
- 7.4.1 China Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Type
- 7.4.2 China Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Application
- 7.5 Rest of World
- 7.5.1 Rest of World Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Type
- 7.5.2 Rest of World Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Application
- 7.5.1 Japan
- 7.5.2 Korea
- 7.5.3 India
- 7.5.4 Southeast Asia
8 Company Profiles
- 8.1 Johnson & Johnson
- 8.1.1 Johnson & Johnson Company Details
- 8.1.2 Company Description and Business Overview
- 8.1.3 Production and Revenue of Diphtheria, Pertussis, and Tetanus Vaccine
- 8.1.4 Diphtheria, Pertussis, and Tetanus Vaccine Product Introduction
- 8.1.5 Johnson & Johnson Recent Development
- 8.2 GlaxoSmithKline
- 8.2.1 GlaxoSmithKline Company Details
- 8.2.2 Company Description and Business Overview
- 8.2.3 Production and Revenue of Diphtheria, Pertussis, and Tetanus Vaccine
- 8.2.4 Diphtheria, Pertussis, and Tetanus Vaccine Product Introduction
- 8.2.5 GlaxoSmithKline Recent Development
- 8.3 Sanofi
- 8.3.1 Sanofi Company Details
- 8.3.2 Company Description and Business Overview
- 8.3.3 Production and Revenue of Diphtheria, Pertussis, and Tetanus Vaccine
- 8.3.4 Diphtheria, Pertussis, and Tetanus Vaccine Product Introduction
- 8.3.5 Sanofi Recent Development
- 8.4 Lanzhou Institute of Biological
- 8.4.1 Lanzhou Institute of Biological Company Details
- 8.4.2 Company Description and Business Overview
- 8.4.3 Production and Revenue of Diphtheria, Pertussis, and Tetanus Vaccine
- 8.4.4 Diphtheria, Pertussis, and Tetanus Vaccine Product Introduction
- 8.4.5 Lanzhou Institute of Biological Recent Development
- 8.5 Merck
- 8.5.1 Merck Company Details
- 8.5.2 Company Description and Business Overview
- 8.5.3 Production and Revenue of Diphtheria, Pertussis, and Tetanus Vaccine
- 8.5.4 Diphtheria, Pertussis, and Tetanus Vaccine Product Introduction
- 8.5.5 Merck Recent Development
- 8.6 Novartis
- 8.6.1 Novartis Company Details
- 8.6.2 Company Description and Business Overview
- 8.6.3 Production and Revenue of Diphtheria, Pertussis, and Tetanus Vaccine
- 8.6.4 Diphtheria, Pertussis, and Tetanus Vaccine Product Introduction
- 8.6.5 Novartis Recent Development
- 8.7 AstraZeneca
- 8.7.1 AstraZeneca Company Details
- 8.7.2 Company Description and Business Overview
- 8.7.3 Production and Revenue of Diphtheria, Pertussis, and Tetanus Vaccine
- 8.7.4 Diphtheria, Pertussis, and Tetanus Vaccine Product Introduction
- 8.7.5 AstraZeneca Recent Development
- 8.8 Emergent
- 8.8.1 Emergent Company Details
- 8.8.2 Company Description and Business Overview
- 8.8.3 Production and Revenue of Diphtheria, Pertussis, and Tetanus Vaccine
- 8.8.4 Diphtheria, Pertussis, and Tetanus Vaccine Product Introduction
- 8.8.5 Emergent Recent Development
- 8.9 Astellas
- 8.9.1 Astellas Company Details
- 8.9.2 Company Description and Business Overview
- 8.9.3 Production and Revenue of Diphtheria, Pertussis, and Tetanus Vaccine
- 8.9.4 Diphtheria, Pertussis, and Tetanus Vaccine Product Introduction
- 8.9.5 Astellas Recent Development
9 Market Forecast
- 9.1 Global Market Size Forecast
- 9.1.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Capacity, Production Forecast 2019-2025
- 9.1.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Value Forecast 2019-2025
- 9.2 Market Forecast by Regions
- 9.2.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Production and Value Forecast by Regions 2019-2025
- 9.2.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Consumption Forecast by Regions 2019-2025
- 9.3 United States
- 9.3.1 Production and Value Forecast in United States
- 9.3.2 Consumption Forecast in United States
- 9.4 European Union
- 9.4.1 Production and Value Forecast in European Union
- 9.4.2 Consumption Forecast in European Union
- 9.5 China
- 9.5.1 Production and Value Forecast in China
- 9.5.2 Consumption Forecast in China
- 9.6 Rest of World
- 9.6.1 Japan
- 9.6.2 Korea
- 9.6.3 India
- 9.6.4 Southeast Asia
- 9.7 Forecast by Type
- 9.7.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Forecast by Type
- 9.7.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Value Forecast by Type
- 9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
- 10.1 Value Chain Analysis
- 10.2 Sales Channels Analysis
- 10.2.1 Diphtheria, Pertussis, and Tetanus Vaccine Sales Channels
- 10.2.2 Diphtheria, Pertussis, and Tetanus Vaccine Distributors
- 10.3 Diphtheria, Pertussis, and Tetanus Vaccine Customers
11 Opportunities & Challenges, Threat and Affecting Factors
- 11.1 Market Opportunities
- 11.2 Market Challenges
- 11.3 Porter's Five Forces Analysis
12 Key Findings
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.1.1 Research Programs/Design
- 13.1.1.2 Market Size Estimation
- 13.1.1.3 Market Breakdown and Data Triangulation
- 13.1.2 Data Source
- 13.1.2.1 Secondary Sources
- 13.1.2.2 Primary Sources
- 13.1.1 Methodology/Research Approach
- 13.2 Author Details
Summary:
Get latest Market Research Reports on Diphtheria, Pertussis, and Tetanus Vaccine. Industry analysis & Market Report on Diphtheria, Pertussis, and Tetanus Vaccine is a syndicated market report, published as Global (United States, European Union and China) Diphtheria, Pertussis, and Tetanus Vaccine Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Diphtheria, Pertussis, and Tetanus Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
